AGAPITO L FAJARDO
Allopathic & Osteopathic Physicians|General Practice CLINTON, NC NPI 1790733855
Browse related groups: Allopathic & Osteopathic Physicians|General Practice NC Supernus Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$1,180.51
- Category: General Payments
- Program years: PY2018–2020
- Record count: 83
- As of (CMS publication): 2026-01-23
Latest program year (PY2020): $124.16 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2020) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $124.16 | 7 |
By paying entity
Latest program year (PY2020) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $39.56 | 1 |
| SANOFI-AVENTIS U.S. LLC | $28.23 | 2 |
| Acerta Pharma LLC | $25.96 | 2 |
| GlaxoSmithKline, LLC. | $15.30 | 1 |
| Novo Nordisk AS | $15.11 | 1 |
By program year
Records — PY2020 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 736108027 | AstraZeneca Pharmaceuticals LP | $12.24 | 02/26/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 736403141 | AstraZeneca Pharmaceuticals LP | $13.72 | 03/04/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 738705643 | GlaxoSmithKline, LLC. | $15.30 | 01/29/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 744026485 | SANOFI-AVENTIS U.S. LLC | $11.83 | 02/12/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 744026499 | SANOFI-AVENTIS U.S. LLC | $16.40 | 03/11/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 744655757 | Novo Nordisk Inc | $15.11 | 01/22/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 748332973 | Supernus Pharmaceuticals, Inc. | $39.56 | 01/29/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.